F144 Long-term effect of a HMG-CoA reductase inhibitor, pravastatin, in glomerulonephritis patients with hyperlipidaemia: an 18-month experience

Atherosclerosis ◽

10.1016/s0021-9150(97)84613-8 ◽

1998 ◽

Vol 136 ◽

pp. S56

Author(s):

Hung-Hsiang Liou ◽

Mei-Chyn Liu

Keyword(s):

Reductase Inhibitor ◽

Term Effect ◽

Hmg Coa Reductase ◽

Long Term Effect ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

P-7-29 Long term effect of the HMG CoA reductase inhibitor (CS-514) on lipid and glucose metabolism of hyperlipidemic diabetics

Diabetes Research and Clinical Practice ◽

10.1016/0168-8227(87)90147-1 ◽

1987 ◽

Vol 3 ◽

pp. S76

Keyword(s):

Glucose Metabolism ◽

Reductase Inhibitor ◽

Term Effect ◽

Hmg Coa Reductase ◽

Long Term Effect ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia

Atherosclerosis ◽

10.1016/s0021-9150(01)00765-1 ◽

2002 ◽

Vol 163 (1) ◽

pp. 157-164 ◽

Author(s):

Yoshihiro Noji ◽

Toshinori Higashikata ◽

Akihiro Inazu ◽

Atsushi Nohara ◽

Kosei Ueda ◽

...

Keyword(s):

Familial Hypercholesterolemia ◽

Reductase Inhibitor ◽

Term Treatment ◽

Hmg Coa Reductase ◽

Heterozygous Familial Hypercholesterolemia ◽

Long Term Treatment ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

1P-0091 Long-term combination therapy with an HMG-COA reductase inhibitor, pravastatin, and an ACE inhibitor, captopril, seems to be beneficial for hypercholesterolemic hypertensives

Atherosclerosis Supplements ◽

10.1016/s1567-5688(03)90166-8 ◽

2003 ◽

Vol 4 (2) ◽

pp. 39

Author(s):

H. Shionoiri ◽

I. Takasaki ◽

F. Shionoiri

Keyword(s):

Combination Therapy ◽

Reductase Inhibitor ◽

Ace Inhibitor ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

A long-term comparative trial of cerivastatin sodium, a new HMG-CoA reductase inhibitor, in patients with primary hypercholesterolemia

Clinical Therapeutics ◽

10.1016/s0149-2918(98)80063-5 ◽

1998 ◽

Vol 20 (3) ◽

pp. 539-548 ◽

Author(s):

Jun Sasaki ◽

Kikuo Arakawa ◽

Kyosuke Yamamoto ◽

Shozo Kobori ◽

Masato Ageta ◽

...

Keyword(s):

Reductase Inhibitor ◽

Comparative Trial ◽

Hmg Coa Reductase ◽

Primary Hypercholesterolemia ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

The Effects of Long Term Use of HMG-CoA Reductase Inhibitor on the Level of Lp (a)

Korean Circulation Journal ◽

10.4070/kcj.1999.29.12.1350 ◽

1999 ◽

Vol 29 (12) ◽

pp. 1350

Author(s):

Jin Won Kim ◽

Hong Seog Seo ◽

Sung Hee Sin ◽

Yung Jae Oh ◽

Jung Chun Ahn ◽

...

Keyword(s):

Reductase Inhibitor ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

Effect of long-term HMG-CoA-reductase inhibitor therapy on large artery endothelial function and distensibility after kidney transplantation

American Journal of Hypertension ◽

10.1016/s0895-7061(03)00453-9 ◽

2003 ◽

Vol 16 (5) ◽

pp. A141

Author(s):

U HILLEBRANDT

Keyword(s):

Kidney Transplantation ◽

Endothelial Function ◽

Reductase Inhibitor ◽

Inhibitor Therapy ◽

Large Artery ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

Long-term administration of the HMG-CoA reductase inhibitor lovastatin in two patients with cholesteryl ester storage disease

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cpp39199 ◽

2001 ◽

Vol 39 (05) ◽

pp. 199-204 ◽

Author(s):

F. Rassoul ◽

V. Richter ◽

P. Lohse ◽

A. Naumann ◽

K. Purschwitz ◽

...

Keyword(s):

Cholesteryl Ester ◽

Reductase Inhibitor ◽

Storage Disease ◽

Hmg Coa Reductase ◽

Term Administration ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

Long-term effects of NK-104 (itavastatin), a new HMG-CoA reductase inhibitor, in patients with heterozygous familial hypercholesterolemia

Atherosclerosis ◽

10.1016/s0021-9150(00)80237-3 ◽

2000 ◽

Vol 151 (1) ◽

pp. 53 ◽

Author(s):

H Mabuchi

Keyword(s):

Familial Hypercholesterolemia ◽

Reductase Inhibitor ◽

Long Term Effects ◽

Hmg Coa Reductase ◽

Heterozygous Familial Hypercholesterolemia ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

Clinical efficacy of fluvastatin, a new synthetic HMG-CoA reductase inhibitor, in long-term treatment of hyperlipidemia; results of a multicenter long-term study

Atherosclerosis ◽

10.1016/0021-9150(94)93674-9 ◽

1994 ◽

Vol 109 (1-2) ◽

pp. 166

Author(s):

T. Teramoto ◽

Y. Goto

Keyword(s):

Clinical Efficacy ◽

Reductase Inhibitor ◽

Term Treatment ◽

Hmg Coa Reductase ◽

Long Term Study ◽

Long Term Treatment ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

Long-Term Combination Therapy with an ACE Inhibitor, Captopril, and an HMG-CoA Reductase Inhibitor, Pravastatin, Is Beneficial for Hypercholesterolemic Hypertensives: an Observational Study

Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ◽

10.3999/jscpt.35.5_257 ◽

2004 ◽

Vol 35 (5) ◽

pp. 257-262

Author(s):

Hiroshi SHIONOIRP ◽

Izumi TAKASAKI ◽

Futoshi SHIONOIRI

Keyword(s):

Combination Therapy ◽

Observational Study ◽

Reductase Inhibitor ◽

Ace Inhibitor ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text